Literature DB >> 16262618

Cytotoxicity analysis of alendronate on cultured endothelial cells and subcutaneous tissue. a pilot study.

Maria Stella Moreira1, Emilio Katayama, Antonio Carlos Bombana, Márcia Martins Marques.   

Abstract

The use of alendronate, a bisphosphonate which is able to inhibit bone resorption, in order to prevent dental root resorption after tooth replantation would be of clinical relevance. However, this drug must be biocompatible to the periapical tissues. The aim of this study was to analyze the effect of an alendronate paste in polyethyleneglycol (2 g ml(-1)) on endothelial cells in culture (in vitro) and on rat subcutaneous tissue (in vivo). For the in vitro study the paste was applied on round glass coverslips that were immersed into confluent cell cultures (clone Cips). The cell viability percentages of these cultures were obtained 0, 6 and 12 h after contact with the substance. As control, cultures that received plain coverslips were used. This analysis was carried out in triplicate using the Trypan blue dye exclusion assay. For the in vivo study the paste was introduced into polyethylene tubes that were placed into the rat subcutaneous tissue. The rats were killed 7 and 14 days later; then, the tissue sections stained with hematoxylin-eosin were analyzed. In vitro, the alendronate caused a significant decrease in the cell viability in 6 h (P < 0.05) and 12 h (P < 0.01), when compared with the control cultures. In vivo the tissue response was exuberant and similar at the two experimental times. There was a necrosis in a comprehensive area in contact with the open end of the tube. Presence of micro-abscesses and intense inflammatory infiltrate in the hypoderm permeating the muscle fibers and fat lobules were observed. In conclusion, the alendronate paste in polyethylene glycol as used showed to be highly cytotoxic in vitro as well as in vivo.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16262618     DOI: 10.1111/j.1600-9657.2005.00370.x

Source DB:  PubMed          Journal:  Dent Traumatol        ISSN: 1600-4469            Impact factor:   3.333


  12 in total

1.  Mandible matrix necrosis in beagle dogs after 3 years of daily oral bisphosphonate treatment.

Authors:  Matthew R Allen; David B Burr
Journal:  J Oral Maxillofac Surg       Date:  2008-05       Impact factor: 1.895

2.  The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study.

Authors:  Andreas M Pabst; Thomas Ziebart; Felix P Koch; Katherine Y Taylor; Bilal Al-Nawas; Christian Walter
Journal:  Clin Oral Investig       Date:  2011-01-12       Impact factor: 3.573

Review 3.  Osteonecrosis of the jaws: clinicopathologic and radiologic characteristics, preventive and therapeutic strategies.

Authors:  Vassilios Vassiliou; Nikolaos Tselis; Dimitrios Kardamakis
Journal:  Strahlenther Onkol       Date:  2010-04-26       Impact factor: 3.621

4.  A role of oral bacteria in bisphosphonate-induced osteonecrosis of the jaw.

Authors:  H Mawardi; G Giro; M Kajiya; K Ohta; S Almazrooa; E Alshwaimi; S-B Woo; I Nishimura; T Kawai
Journal:  J Dent Res       Date:  2011-09-15       Impact factor: 6.116

5.  Femur bone repair in ovariectomized rats under the local action of alendronate, hydroxyapatite and the association of alendronate and hydroxyapatite.

Authors:  Antonio Carlos Victor Canettieri; Carlos Eduardo Dias Colombo; Chung Man Chin; Horácio Faig-Leite
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

6.  Dental risk factors for osteonecrosis of the jaws: a CONDOR case-control study.

Authors:  A Barasch; J Cunha-Cruz; F Curro; T DeRouen; G H Gilbert; P Hujoel; M M Safford; D A Vena; A E Voinea-Griffin; H Wu
Journal:  Clin Oral Investig       Date:  2012-12-02       Impact factor: 3.573

7.  Comparing subcutaneous tissue responses to freshly mixed and set root canal sealers.

Authors:  Setareh Derakhshan; Alireza Adl; Masoud Parirokh; Fatemeh Mashadiabbas; Ali Akbar Haghdoost
Journal:  Iran Endod J       Date:  2009-10-10

8.  The susceptive alendronate-treatment timing and dosage for osteogenesis enhancement in human bone marrow-derived stem cells.

Authors:  Chih-Hsiang Chang; Chau-Zen Wang; Je-Ken Chang; Che-Yu Hsu; Mei-Ling Ho
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

Review 9.  Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ).

Authors:  Britt-Isabelle Berg; Andreas A Mueller; Marcello Augello; Scott Berg; Claude Jaquiéry
Journal:  Dent J (Basel)       Date:  2016-09-02

Review 10.  Management of Root Resorption Using Chemical Agents: A Review.

Authors:  Zahed Mohammadi; Zafer C Cehreli; Sousan Shalavi; Luciano Giardino; Flavio Palazzi; Saeed Asgary
Journal:  Iran Endod J       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.